Veronica Di Cristanziano
Overview
Explore the profile of Veronica Di Cristanziano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thierbach A, Di Cristanziano V, Eberhardt K, Pirkl M, Steger G, Heger E, et al.
J Clin Virol
. 2025 Feb;
177:105774.
PMID: 39985863
Background: Immunocompromised individuals, hemato-oncologic diseases or post-transplantation included, are, due to impaired immune response, at increased risk for severe and prolonged COVID-19. Observational Studies showed that SARS-CoV-2 RNAemia has been...
2.
Loyal L, Braun J, Reimer U, Meyer-Arndt L, Henze L, Kruse B, et al.
Cell Rep
. 2025 Feb;
44(2):115314.
PMID: 39960834
Repeated vaccinations and infections have led to diverse states of hybrid immunity against SARS-CoV-2 in the global population. However, age and comorbidities can compromise protection against severe disease, and antibody-mediated...
3.
Frickmann H, Sarfo F, Norman B, Dompreh A, Asibey S, Boateng R, et al.
Pathogens
. 2025 Jan;
13(12.
PMID: 39770313
Although the etiological relevance of the detection of microsporidia in human stool samples remains uncertain, the immunological status of patients has been posited as an important determinant of potential clinical...
4.
Steinke J, Di Cristanziano V, Naendrup J, Cadar D, Gabriel M, Grosser R, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Dec;
44(3):747-752.
PMID: 39731618
Dengue is an increasing threat to individuals living in or visiting endemic countries. Effective vaccines have become available, but their use in travelers is typically only recommended to individuals with...
5.
Antonetti L, Berrilli F, Di Cristanziano V, Farowski F, Daeumer M, Eberhardt K, et al.
Gut Pathog
. 2024 Nov;
16(1):72.
PMID: 39614306
The composition of human gut microbiota is dominated by bacteria which have been extensively studied. The role of intestinal eukaryote microorganisms like Blastocystis, however, remains under investigation. Moreover, the potential...
6.
Sarfo F, Frickmann H, Dompreh A, Asibey S, Boateng R, Weinreich F, et al.
Microorganisms
. 2024 Nov;
12(11).
PMID: 39597540
There is a paucity of information on the prevalence, risk factors, and clinical correlates of people living with HIV (PLWH) who are co-infected with spp. in the post-combined antiretroviral therapy...
7.
Fuchs F, Frickmann H, Hahn A, Balczun C, Hagen R, Feldt T, et al.
J Med Microbiol
. 2024 Oct;
73(10).
PMID: 39392223
. Fungal infections are relevant health risks for individuals with acquired immunodeficiency in the resource-limited tropics, but available surveillance data are scarce. For and spp., the evolution from environmental reservoirs...
8.
Backhaus J, Kann S, Hahn A, Weinreich F, Blohm M, Tanida K, et al.
Pathogens
. 2024 Jul;
13(7).
PMID: 39057810
The study was conducted to identify cluster patterns of enteric microorganisms with potential etiological relevance for infectious gastroenteritis in stool samples of individuals from Ghana, which is a known high-endemicity...
9.
Esser P, Quintanares G, Langhans B, Heger E, Bohm M, Jensen B, et al.
J Infect Dis
. 2024 Jan;
230(2):e437-e446.
PMID: 38230877
Background: Torque teno virus (TTV) is part of the human virome. TTV load was related to the immune status in patients after organ transplantation. We hypothesize that TTV load could...
10.
Trappe M, Affeldt P, Grundmann F, Kann M, Koehler F, Muller R, et al.
Transpl Infect Dis
. 2024 Jan;
26(1):e14233.
PMID: 38180168
Background: Cytomegalovirus (CMV) infections are a common complication after kidney transplantation (KTx) and negatively affecting patient outcome. Valganciclovir (VGC) prophylaxis is often limited by drug-induced side effects and dose reduction...